3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
6
Fallopian Tube Neoplasms
4
Carcinoma, Ovarian Epithelial
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Platinum-resistant Ovarian Cancer
1
Ovarian Cancer Recurrent
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Adenoviridae Infections
1
Interventions
Cisplatin
26
Paclitaxel
21
pembrolizumab
15
Radiotherapy
13
Carboplatin
13
tislelizumab
12
Fluorouracil
12
Drug Therapy
11
Irinotecan
9
toripalimab
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Neoadjuvant Therapy
5
Leucovorin
5
Docetaxel
5
lenvatinib
4
camrelizumab
4
Taxes
4
Radiation
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
spartalizumab
3
sintilimab
3
apatinib
3
Itraconazole
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
1-dodecylpyridoxal
×
1 year
×
Clear all
No trials found.